Dec 5, 2018 | Oncology, Science Spotlight
Giuseppe Lentini, MD Senior Medical Director, Hematology/Oncology – Medical Affairs DECEMBER 5, 2018 Since the approval of the first IND for CD19 CAR T-cell therapy, which was approved and filed in 2007, tremendous advancements have been made in hemato-oncology...
Sep 20, 2018 | Rare Diseases, Science Spotlight
Rare Dermatology Greg Licholai, MD Chief Medical Information Officer SEPTEMBER 20, 2018 Rare dermatological diseases are under-represented in drug development and pharmaceutical company-sponsored trials — only about one-tenth of non-oncology rare dermatological...
Apr 5, 2018 | Rare Diseases, Science Spotlight
Rare Diseases Newsletter: April 2018 Scott Schliebner VP, Scientific Affairs JANUARY 10, 2018 With only 5% of rare diseases having even one approved treatment option, millions of patients around the globe are left without treatment. However, advanced therapies hold...
Jan 5, 2018 | Rare Diseases, Science Spotlight
Rare Diseases Newsletter: January 2018 Scott Schliebner VP, Scientific Affairs JANUARY 10, 2018 There are two broad categories of Hemolytic Uremic Syndromes (HUS), typical HUS and atypical HUS (aHUS), both of which cause a rare and devastating disease. Read about aHUS...
Dec 7, 2017 | Science Spotlight
The Changing Landscape of ADME Studies Ad F. Roffel, Ph.D. Director of Scientific Affairs – Clinical Pharmacology DECEMBER 7, 2017 In September, Ad F. Roffel, Ph.D., Director of Scientific Affairs – Clinical Pharmacology, presented in Munich, Germany on The...
Recent Comments